Nifty

:

25471.10

Sensex

:

82626.76

-336.10 (-1.30%)
-1048.16 (-1.25%)

Login

Nifty
Sensex

:
:

25471.10
82626.76

-336.10 (-1.30%)
-1048.16 (-1.25%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

69/99

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

1974.60

13-Feb-2026

Open
High
Low
Previous Close

2004.9
2012.3
1953.1
2004.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5685
11310065.3
2725
1835

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,271.75
16.15
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,139.95
1.21%
5.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.87
10.92
8.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.70
17.57
8.96

PAT CAGR (%)

10 Years
5 Years
3 Years

31.76
35.58
39.40

P:E (Median)

8 Years
5 Years
3 Years

22.17
22.24
28.61

P:BV (Average)

8 Years
5 Years
3 Years

5.41
5.92
7.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.72
16.55
20.01

Earnings Forecasts:

(Updated: 07-02-2026)

Description 2024 2025 2026 2027
Adj EPS 110.8 60 77.7 91.4
P/E Ratio 17.82 32.91 25.41 21.60
Revenue 653.43 684.8 776.3 870.9
EBITDA 159.65 144.1 180.9 212.5
Net Income 183.24 99.3 128.5 151.2
ROA 31.3
P/B Ratio 6.16 5.89 4.97 4.20
ROE 40.48 18.4 19.6 19.4
FCFF 44.42 29.1 59.6 111.4
FCFF Yield 1.48 0.97 1.99 3.72
Net Debt -265.51
BVPS 320.77 335 397.2 470.3

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 180.03 172.71 4.24% 181.68 172.21 5.50% 168.92 165.42 2.12% 143.09 126.99 12.68%
Expenses 140.27 123.55 13.53% 142.65 126.28 12.96% 133.45 126.35 5.62% 117.60 106.27 10.66%
EBITDA 39.76 49.16 -19.12% 39.03 45.93 -15.02% 35.47 39.07 -9.21% 25.49 20.72 23.02%
EBIDTM 22.09% 28.46% 21.48% 26.67% 21.00% 23.62% 17.81% 16.32%
Other Income 3.41 3.31 3.02% 4.54 1.94 134.02% 5.23 2.37 120.68% 5.06 1.65 206.67%
Interest 0.25 0.12 108.33% 0.12 0.17 -29.41% 0.13 0.15 -13.33% 0.18 0.14 28.57%
Depreciation 5.38 5.46 -1.47% 5.22 5.31 -1.69% 5.14 5.29 -2.84% 5.37 4.49 19.60%
PBT 29.12 46.89 -37.90% 49.45 15.09 227.70% 35.43 36.00 -1.58% 134.90 17.74 660.43%
Tax 6.99 11.96 -41.56% 12.60 10.89 15.70% 9.14 9.24 -1.08% 17.55 4.50 290.00%
PAT 22.13 34.93 -36.64% 36.85 4.20 777.38% 26.29 26.76 -1.76% 117.35 13.24 786.33%
PATM 12.29% 20.22% 20.28% 2.44% 15.56% 16.18% 82.01% 10.43%
EPS 13.41 21.17 -36.66% 22.33 2.55 775.69% 15.93 16.22 -1.79% 71.12 8.02 786.78%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 180.03 172.71 4.24% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 140.27 123.55 13.53% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 39.76 49.16 -19.12% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 22.09% 28.46% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 3.41 3.31 3.02% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.25 0.12 108.33% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 5.38 5.46 -1.47% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 29.12 46.89 -37.90% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 6.99 11.96 -41.56% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 22.13 34.93 -36.64% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 12.29% 20.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 13.38 21.12 -36.65% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 673.72 653.43 582.05 512.81 440.16 389.14 375.57 330.16 343.95 293.64 279.32 Net Sales Growth 5.71% 12.26% 13.50% 16.51% 13.11% 3.61% 13.75% -4.01% 17.13% 5.13% Cost Of Goods Sold 240.22 196.65 167.82 156.64 127.59 121.27 119.63 103.93 106.87 96.02 84.94 Gross Profit 433.50 456.78 414.23 356.17 312.57 267.87 255.94 226.23 237.08 197.62 194.38 GP Margin 64.34% 69.90% 71.17% 69.45% 71.01% 68.84% 68.15% 68.52% 68.93% 67.30% 69.59% Total Expenditure 533.97 494.46 452.91 409.28 353.00 318.37 315.67 295.73 306.89 265.01 257.02 Power & Fuel Cost - 17.66 14.36 13.65 12.69 11.27 11.54 10.38 10.44 9.10 11.23 % Of Sales - 2.70% 2.47% 2.66% 2.88% 2.90% 3.07% 3.14% 3.04% 3.10% 4.02% Employee Cost - 126.14 132.15 117.06 99.97 94.66 90.97 89.93 90.14 75.59 74.13 % Of Sales - 19.30% 22.70% 22.83% 22.71% 24.33% 24.22% 27.24% 26.21% 25.74% 26.54% Manufacturing Exp. - 46.35 43.80 36.62 37.86 28.79 21.85 18.98 21.86 20.63 26.88 % Of Sales - 7.09% 7.53% 7.14% 8.60% 7.40% 5.82% 5.75% 6.36% 7.03% 9.62% General & Admin Exp. - 48.64 41.63 37.14 33.97 28.54 32.76 34.32 35.76 31.57 24.58 % Of Sales - 7.44% 7.15% 7.24% 7.72% 7.33% 8.72% 10.39% 10.40% 10.75% 8.80% Selling & Distn. Exp. - 46.22 37.85 35.62 32.27 25.47 20.13 18.61 22.51 17.90 16.44 % Of Sales - 7.07% 6.50% 6.95% 7.33% 6.55% 5.36% 5.64% 6.54% 6.10% 5.89% Miscellaneous Exp. - 12.80 15.30 12.55 8.65 8.37 18.79 19.58 19.31 14.20 16.44 % Of Sales - 1.96% 2.63% 2.45% 1.97% 2.15% 5.00% 5.93% 5.61% 4.84% 6.74% EBITDA 139.75 158.97 129.14 103.53 87.16 70.77 59.90 34.43 37.06 28.63 22.30 EBITDA Margin 20.74% 24.33% 22.19% 20.19% 19.80% 18.19% 15.95% 10.43% 10.77% 9.75% 7.98% Other Income 18.24 14.33 7.21 4.80 3.08 1.07 0.99 0.80 2.36 9.78 1.96 Interest 0.68 1.59 1.44 1.15 1.41 1.79 2.76 4.86 4.72 3.64 2.49 Depreciation 21.11 21.43 17.07 15.50 15.66 16.47 16.36 15.32 14.34 11.31 10.15 PBT 248.90 150.28 117.84 91.68 73.17 53.58 41.77 15.05 20.36 23.46 11.62 Tax 46.28 49.64 30.18 24.04 21.69 13.58 7.44 4.24 6.91 2.45 0.00 Tax Rate 18.59% 21.32% 25.61% 26.22% 29.64% 25.35% 20.41% 28.17% 33.94% 10.44% 0.00% PAT 202.62 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 PAT before Minority Interest 202.62 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.07% 28.04% 15.06% 13.19% 11.70% 10.28% 7.72% 3.27% 3.91% 7.16% 4.16% PAT Growth 156.06% 109.03% 29.60% 31.39% 28.70% 37.88% 168.36% -19.63% -35.98% 80.81% EPS 122.80 111.05 53.13 40.99 31.20 24.24 17.58 6.55 8.15 12.73 7.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 530.53 374.85 307.60 255.77 216.45 176.57 160.50 154.75 147.01 133.59 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 517.30 361.62 294.37 242.54 203.22 163.34 147.27 141.52 133.78 120.36 Non-Current Liabilities 6.45 6.48 8.97 8.73 7.19 8.75 9.58 8.37 10.77 22.45 Secured Loans 0.00 0.00 0.00 0.01 0.08 0.22 4.63 10.11 15.89 0.13 Unsecured Loans 0.00 0.00 0.00 0.29 0.66 1.30 1.95 0.12 0.16 0.11 Long Term Provisions 4.54 4.03 3.98 3.04 3.13 8.50 6.19 2.79 2.32 19.60 Current Liabilities 119.83 130.96 102.78 80.11 79.69 82.59 77.82 120.71 78.68 66.80 Trade Payables 79.39 71.02 64.69 45.50 47.44 44.41 25.13 51.87 28.65 33.71 Other Current Liabilities 24.33 45.05 26.23 19.87 18.12 20.30 13.32 18.47 14.91 10.17 Short Term Borrowings 0.00 0.00 0.00 0.21 0.52 5.12 29.04 37.92 24.01 21.96 Short Term Provisions 16.11 14.89 11.86 14.53 13.61 12.76 10.33 12.45 11.11 0.96 Total Liabilities 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84 Net Block 171.83 113.53 124.26 103.71 113.30 122.89 127.64 130.80 136.67 109.26 Gross Block 276.05 221.52 220.01 186.37 180.44 173.81 162.55 150.65 142.43 189.83 Accumulated Depreciation 104.22 107.99 95.75 82.66 67.14 50.92 34.91 19.85 5.76 80.57 Non Current Assets 191.56 214.20 155.30 137.70 127.48 142.13 150.81 141.21 140.08 135.65 Capital Work in Progress 16.06 96.31 25.44 31.06 11.77 9.98 17.17 8.73 1.82 1.59 Non Current Investment 1.01 1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.66 3.35 5.60 2.93 2.41 9.26 6.00 1.68 1.59 24.80 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 465.25 298.09 264.05 206.91 175.85 125.78 97.09 142.62 96.38 87.19 Current Investments 125.90 90.15 58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 92.98 101.00 95.05 82.99 58.33 46.61 41.04 53.69 45.78 39.02 Sundry Debtors 86.76 49.13 37.43 32.99 57.42 63.33 38.90 68.13 39.28 36.99 Cash & Bank 139.61 36.47 57.04 70.26 40.75 1.11 0.77 0.94 1.60 0.80 Other Current Assets 20.00 4.86 5.41 6.64 19.35 14.73 16.38 19.86 9.72 10.38 Short Term Loans & Adv. 9.89 16.48 10.69 14.03 10.64 6.51 9.45 12.26 4.13 9.80 Net Current Assets 345.42 167.13 161.27 126.80 96.16 43.19 19.27 21.91 17.70 20.39 Total Assets 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 77.86 94.36 90.82 64.75 58.27 50.17 45.78 14.68 7.33 32.81 PBT 232.88 117.84 91.68 73.17 53.58 36.45 15.05 20.36 23.46 11.62 Adjustment -76.22 12.92 13.31 13.54 16.55 22.52 20.08 17.37 6.95 12.64 Changes in Working Capital -26.05 -7.09 11.06 -3.11 -3.53 -2.37 14.37 -19.35 -18.81 10.92 Cash after chg. in Working capital 130.61 123.67 116.05 83.60 66.60 56.60 49.50 18.38 11.60 35.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -52.75 -29.31 -25.23 -18.85 -8.33 -6.43 -3.72 -3.70 -4.27 -2.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.80 -79.15 -105.81 -34.66 -7.96 -10.70 -19.02 -15.54 -30.06 -15.25 Net Fixed Assets 25.72 -72.38 -28.02 -25.22 -8.42 -4.07 -20.34 -15.13 47.17 -15.19 Net Investments -35.75 -32.73 -58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -31.77 25.96 -19.36 -9.44 0.46 -6.63 1.32 -0.41 -77.23 -0.06 Cash from Financing Activity -27.08 -20.31 -17.12 -13.51 -10.49 -39.30 -26.50 0.11 23.36 -17.58 Net Cash Inflow / Outflow 8.98 -5.10 -32.11 16.58 39.82 0.17 0.26 -0.75 0.63 -0.02 Opening Cash & Equivalents 19.72 24.82 56.93 40.36 0.54 0.37 0.11 0.86 0.23 0.25 Closing Cash & Equivalent 28.70 19.72 24.82 56.94 40.36 0.54 0.37 0.11 0.86 0.23

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 320.80 226.67 186.00 154.66 130.88 106.77 97.05 93.58 88.89 80.78 ROA 31.35% 18.82% 17.71% 15.89% 14.00% 11.25% 4.07% 5.17% 9.15% 5.34% ROE 40.48% 25.69% 24.01% 21.80% 20.36% 17.21% 6.86% 8.91% 14.98% 8.98% ROCE 51.79% 34.96% 32.92% 31.46% 27.27% 20.35% 9.81% 12.52% 15.58% 8.97% Fixed Asset Turnover 2.82 2.83 2.73 2.61 2.37 2.23 2.11 2.37 1.85 1.59 Receivable days 35.40 25.32 23.17 34.41 52.52 49.68 59.16 56.47 45.37 48.80 Inventory Days 50.53 57.35 58.57 53.79 45.64 42.59 52.36 52.29 50.44 46.22 Payable days 139.59 147.58 128.38 132.94 138.23 44.01 56.38 53.51 47.24 47.03 Cash Conversion Cycle -53.67 -64.92 -46.65 -44.74 -40.07 48.25 55.15 55.25 48.57 47.99 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.07 0.23 0.35 0.30 0.17 Interest Cover 147.47 82.83 80.72 52.89 30.93 14.21 4.10 5.31 7.45 5.67

Top Investors:

authum investment and infrastructure limited

quant mutual fund - quant multi cap fund

investor education and protection fund authority ministry of corporate affairs

Annual Reports:

News Update:

RPG Life Sciences - Quarterly Results
28th Jan 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback